Review

Published on 15 Oct 2021

Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?

in Pharmacology of Anti-Cancer Drugs

Zeina N. Al-Mahayri
Mohammad M. AlAhmad
Bassam R. Ali

Frontiers in Oncology

doi 10.3389/fonc.2021.710163

13,898 views
24 citations

Mini Review

Published on 14 Oct 2021

Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy

in Pharmacology of Anti-Cancer Drugs

Jinchun Wu
Yongbin Hu
Omar Abdihamid
Gengwen Huang
Sheng Xiao
Bin Li

Frontiers in Oncology

doi 10.3389/fonc.2021.684865

3,717 views
4 citations

Review

Published on 14 Oct 2021

Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment

in Pharmacology of Anti-Cancer Drugs

Fengqian Chen
Jingquan Li
Hui Wang
Qian Ba

Frontiers in Oncology

doi 10.3389/fonc.2021.746917

7,147 views
25 citations

Case Report

Published on 14 Oct 2021

Case Report: Effective Treatment With Pyrotinib and Capecitabine in a Heavily Pretreated Locally Advanced Breast Cancer Harboring Both HER2 Overexpression and Mutant

in Pharmacology of Anti-Cancer Drugs

Zhichao Gao
Junnan Xu
Yan Wang
Jie Wu
Tao Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.715554

2,995 views
4 citations

Review

Published on 12 Oct 2021

NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma

in Pharmacology of Anti-Cancer Drugs

Cinzia Garofalo
Carmela De Marco
Costanza Maria Cristiani

Frontiers in Oncology

doi 10.3389/fonc.2021.754541

5,514 views
20 citations

Systematic Review

Published on 12 Oct 2021

Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Linhan Jiang
Xiaoxia Tan
Jun Li
Yaling Li

Frontiers in Oncology

doi 10.3389/fonc.2021.726008

4,307 views
3 citations

Mini Review

Published on 11 Oct 2021

Irinotecan-Induced Steatohepatitis: Current Insights

in Pharmacology of Anti-Cancer Drugs

Jun Han
Jing Zhang
Chengliang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.754891

5,686 views
15 citations

Review

Published on 11 Oct 2021

Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?

in Pharmacology of Anti-Cancer Drugs

Zarrin Banikazemi
Seyed Mohammad Mirazimi
Fatemeh Dashti
Mohammad Reza Mazandaranian
Maryam Akbari
Korosh Morshedi
Fatemeh Aslanbeigi
Amir Rashidian
Mohsen Chamanara
Michael R. Hamblin

Frontiers in Oncology

doi 10.3389/fonc.2021.752784

7,691 views
23 citations

Review

Published on 07 Oct 2021

Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases

in Pharmacology of Anti-Cancer Drugs

Ran Yu
Guihua Jin
Manabu Fujimoto

Frontiers in Oncology

doi 10.3389/fonc.2021.722331

9,457 views
33 citations

Case Report

Published on 07 Oct 2021

The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature

in Pharmacology of Anti-Cancer Drugs

Giovanna Garufi
Luisa Carbognin
Armando Orlandi
Antonella Palazzo
Giampaolo Tortora
Emilio Bria

Frontiers in Oncology

doi 10.3389/fonc.2021.651723

5,164 views
10 citations

Original Research

Published on 07 Oct 2021

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses

in Pharmacology of Anti-Cancer Drugs

Selvaraj Vimalraj
Raghunandhakumar Subramanian
Anuradha Dhanasekaran

Frontiers in Oncology

doi 10.3389/fonc.2021.742789

3,232 views
29 citations

Original Research

Published on 06 Oct 2021

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation

in Pharmacology of Anti-Cancer Drugs

Meng Wang
Xue-Zhen Li
Ming-Xing Zhang
Qian-Yu Ye
Ying-Xia Chen
Xu Chang

Frontiers in Oncology

doi 10.3389/fonc.2021.738534

3,309 views
17 citations

Case Report

Published on 05 Oct 2021

Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Ting Liu
Qing Li
Wenjie Zhang
Qing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2021.733955

4,422 views
4 citations

Review

Published on 04 Oct 2021

Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy

in Pharmacology of Anti-Cancer Drugs

Daiana L. Vitale
Antonella Icardi
Paolo Rosales
Fiorella M. Spinelli
Ina Sevic
Laura D. Alaniz

Frontiers in Oncology

doi 10.3389/fonc.2021.710061

4,650 views
28 citations

Systematic Review

Published on 30 Sep 2021

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Dong-Yang Wang
Yi Chen
You Zhang
Ying-Qiang Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.705866

4,990 views
8 citations

Review

Published on 27 Sep 2021

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma

in Pharmacology of Anti-Cancer Drugs

Natalia Di Ianni
Martina Maffezzini
Marica Eoli
Serena Pellegatta

Frontiers in Oncology

doi 10.3389/fonc.2021.747690

4,789 views
13 citations

Navigation group

Articles

Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?

Crizotinib in Sarcomatous Malignancies Harboring ALK Fusion With a Definitive Partner(s): Response and Efficacy

Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment

Case Report: Effective Treatment With Pyrotinib and Capecitabine in a Heavily Pretreated Locally Advanced Breast Cancer Harboring Both HER2 Overexpression and Mutant

NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma

Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis

Irinotecan-Induced Steatohepatitis: Current Insights

Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?

Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases

The Therapeutic Challenge of Disseminated Bone Marrow Metastasis From HR-Positive HER2-Negative Breast Cancer: Case Report and Review of the Literature

LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation

Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review

Targeting the Tumor Extracellular Matrix by the Natural Molecule 4-Methylumbelliferone: A Complementary and Alternative Cancer Therapeutic Strategy

The Balance Between the Effectiveness and Safety for Chemotherapy-Induced Nausea and Vomiting of Different Doses of Olanzapine (10 mg Versus 5 mg): A Systematic Review and Meta-Analysis

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma